Pain Therapeutics Granted $3.5M For Alzheimer’s Study, CEO Talks Micro-Cap Volatility – Benzinga
BenzingaPain Therapeutics, Inc. (NASDAQ: PTIE) is a micro-cap company that has developed several drug candidates, such as an abuse-resistant hydromorphone, an abuse-resistant hydrocodone and an antibody for metastatic melanoma. and more …read more Source:: MicroCap Stock News From Google News
from WordPress https://ift.tt/2O8VQrC
via IFTTT
from WordPress https://ift.tt/2O8VQrC
via IFTTT
Post A Comment
No comments :